Table of Content


Introduction
Heterozygous familial hypercholesterolemia- Overview
Heterozygous familial hypercholesterolemia- Therapeutics Development
Heterozygous familial hypercholesterolemia- Therapeutics Assessment
Heterozygous familial hypercholesterolemia- Companies Involved in Therapeutics Development
Heterozygous familial hypercholesterolemia- Drug Profiles
Heterozygous familial hypercholesterolemia- Dormant Projects
Heterozygous familial hypercholesterolemia- Discontinued Products
Heterozygous familial hypercholesterolemia- Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Heterozygous familial hypercholesterolemia (heFH), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Heterozygous familial hypercholesterolemia (heFH), H2 2020
Number of Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by AD Pharmaceuticals Co Ltd, H2 2020
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Beijing Mabworks Biotech Co Ltd, H2 2020
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Daewoong Co Ltd, H2 2020
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Innovent Biologics Inc, H2 2020
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Madrigal Pharmaceuticals Inc, H2 2020
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by NeuroBo Pharmaceuticals Inc, H2 2020
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Novartis AG, H2 2020
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Regeneron Pharmaceuticals Inc, H2 2020
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Shanghai Junshi Bioscience Co Ltd, H2 2020
Heterozygous familial hypercholesterolemia (heFH) - Pipeline by Zhejiang Hisun Pharmaceutical Co Ltd, H2 2020
Heterozygous familial hypercholesterolemia (heFH) - Dormant Projects, H2 2020
Heterozygous familial hypercholesterolemia (heFH) - Discontinued Products, H2 2020